Metraipolis › archive › dc_d52c6362e2ae

Does CSR performance improve corporate immunity to the COVID-19 pandemic? Evidence from China's stock market — Europe PMC PMID:36052006

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36052006
DOI
10.3389/fpubh.2022.956521
License (as archived)
solo-consultazione
Archived
2026-10-07T20:41:39.565Z
SHA-256 of the archived text
500a8217fb2ecbad4b9479d68a755f333c0d037034e1f1d1963aece61586c4c2
Stable URL of this page
https://metraipolis.com/documento/dc_d52c6362e2ae

How to cite

Does CSR performance improve corporate immunity to the COVID-19 pandemic? Evidence from China's stock market — Europe PMC PMID:36052006 — Europe PMC (en), https://europepmc.org/article/MED/36052006 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d52c6362e2ae (Metraipolis archive dc_d52c6362e2ae, sha256 500a8217fb2ecbad4b9479d68a755f333c0d037034e1f1d1963aece61586c4c2)
BibTeX
@misc{dcd52c6362e2ae,
  title = {Does CSR performance improve corporate immunity to the COVID-19 pandemic? Evidence from China's stock market — Europe PMC PMID:36052006},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36052006},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d52c6362e2ae; sha256 500a8217fb2ecbad4b9479d68a755f333c0d037034e1f1d1963aece61586c4c2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36052006. Agents can read the archived copy with the MCP tool read_document.